InvestorsHub Logo
Followers 74
Posts 9174
Boards Moderated 0
Alias Born 04/25/2002

Re: None

Monday, 11/11/2019 5:07:03 PM

Monday, November 11, 2019 5:07:03 PM

Post# of 785
4 products in the pipeline. 1 rejected for the 3rd time by the FDA, however LPCN will work with the FDA to overcome this setback. Most important... fundamentals look good IMO. High cash to debt ratio, and low float. No need for an R/S, unless the company has concerns about being delisted due to low PPS. I see $1+ over the short term.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent LPCN News